| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.053 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |